Benadryl and Renflexis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benadryl (diphenhydramine hydrochloride) and Renflexis (infliximab-abda). Common drug interactions include neuralgia among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Benadryl and Renflexis. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Benadryl?

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in allergies. eHealthMe is studying from 104,955 Benadryl users. Check the latest studies of Benadryl.

What is Renflexis?

Renflexis has active ingredients of infliximab-abda. eHealthMe is studying from 1,316 Renflexis users. Check the latest studies of Renflexis.



On Aug, 12, 2026

49 people who take Benadryl and Renflexis together, and have interactions are studied.

Benadryl and Renflexis drug interactions.

What are the common drug interactions of Benadryl and Renflexis, by gender? *:

female:

  1. Neuralgia (pain in one or more nerves)
  2. Presyncope
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Restlessness (not able to rest)
  5. Stress
  6. Agitation (state of anxiety or nervous excitement)
  7. Bacterial infection
  8. Blood pressure decreased
  9. Body temperature increased
  10. Cough

male:

  1. Back pain
  2. Chest discomfort
  3. Fatigue (feeling of tiredness)
  4. Feeling hot
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Body temperature increased
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Infusion site erythema (reddening of the skin at infusion site)
  10. Infusion site pain

What are the common drug interactions of Benadryl and Renflexis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Fatigue (feeling of tiredness)
  2. Bacterial infection
  3. Body temperature increased
  4. Drug level decreased
  5. Infusion related reaction
  6. Infusion site erythema (reddening of the skin at infusion site)
  7. Infusion site pain
  8. Infusion site rash
  9. Joint stiffness
  10. Malaise (a feeling of general discomfort or uneasiness)

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Feeling hot
  3. Headache (pain in head)
  4. Heart rate increased
  5. Vomiting
  6. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Erythema (redness of the skin)
  9. Fatigue (feeling of tiredness)
  10. Flushing (the warm, red condition of human skin)

30-39:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Colitis ulcerative (inflammation of colon with ulcer)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Blood pressure systolic increased
  6. Burning sensation
  7. Chest discomfort
  8. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  9. Epigastric discomfort
  10. Erythema (redness of the skin)

40-49:

  1. Vomiting
  2. Abdominal discomfort
  3. Abdominal pain upper
  4. Ankylosing spondylitis (type of arthritis affecting the spine)
  5. Aphonia (inability to produce voice)
  6. Asthenia (weakness)
  7. Asthma
  8. Back pain
  9. Cardiac disorder
  10. Chest discomfort

50-59:

  1. Drug hypersensitivity
  2. Dyspnoea (difficult or laboured respiration)
  3. Flushing (the warm, red condition of human skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Apnoea (suspension of external breathing)
  6. Chest discomfort
  7. Fatigue (feeling of tiredness)
  8. Loss of consciousness
  9. Perfume sensitivity
  10. Speech disorder

60+:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Abdominal pain
  3. Discomfort
  4. Muscle spasms (muscle contraction)
  5. Weight increased
  6. Colitis ulcerative (inflammation of colon with ulcer)
  7. Drug specific antibody present
  8. Dyspnoea (difficult or laboured respiration)
  9. Heart rate increased
  10. Anxiety

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 34.69%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 16 people, 32.65%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 12.24%
  4. Pain: 3 people, 6.12%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Benadryl and Renflexis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benadryl and Renflexis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benadryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Renflexis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benadryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renflexis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and infliximab-abda (the active ingredients of Benadryl and Renflexis, respectively), and Benadryl and Renflexis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: